Phosphorylation of nucleosides and nucleoside analogs by mammalian nucleoside monophosphate kinases

Pharmacology and Therapeutics

Volumn 87, Issue 2-3, 2000, Pages 189-198

  Van Rompay, An R ^a   Johansson, Magnus ^a   Karlsson, Anna ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Anticancer therapy; Antiviral therapy; Monophosphate kinases; Nucleoside analogs; Nucleoside kinases

Indexed keywords

1 BETA DEXTRO ARABINOFURANOSYLADENINE; 2 CHLORODEOXYADENOSINE; 9 (2 PHOSPHONOMETHOXYPROPYL)ADENINE; ADEFOVIR; ADENYLATE KINASE; CIDOFOVIR; CYTARABINE; DIDANOSINE; GEMCITABINE; GUANYLATE KINASE; ISOENZYME; LAMIVUDINE; NUCLEOSIDE; NUCLEOSIDE DERIVATIVE; NUCLEOSIDE MONOPHOSPHATE KINASE; STAVUDINE; THYMIDYLATE KINASE; UNCLASSIFIED DRUG; URIDYLATE CYTIDYLATE KINASE; ZALCITABINE; ZIDOVUDINE;

ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; CELLULAR DISTRIBUTION; CONFERENCE PAPER; DNA SYNTHESIS; DRUG ACTIVATION; DRUG METABOLISM; ENZYME SPECIFICITY; HUMAN; MAMMAL; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; RNA SYNTHESIS; TISSUE DISTRIBUTION;

ANIMAL; CELL CYCLE; HUMAN; MAMMALS; NUCLEOSIDE-PHOSPHATE KINASE; NUCLEOSIDES; NUCLEOTIDES; PHOSPHORYLATION; PHOSPHOTRANSFERASES; SUBSTRATE SPECIFICITY; TISSUE DISTRIBUTION;

EID: 0033796942     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(00)00048-6     Document Type: Review

References (74)

1. Agarwal K.C., Miech R.P., Parks R.E. Jr. Guanylate kinases from human erythrocytes, hog brain, and rat liver. Methods Enzymol. 51:1978;483-490.
2. Ahluwalia G.S., Gao W.Y., Mitsuya H., Johns D.G. 2′,3′-Didehydro-3′-deoxythymidine. regulation of its metabolic activation by modulators of thymidine-5′-triphosphate biosynthesis Mol Pharmacol. 50:1996;160-165.
3. Allderdice P.W., Kaita H., Lewis M., McAlpine P.J., Wong P., Anderson J., Giblett E.R. Segregation of marker loci in families with an inherited paracentric insertion of chromosome 9. Am J Hum Genet. 39:1986;612-617.
4. Arima T., Akiyoshi H., Fujii S. Characterization of pyrimidine nucleoside monophosphokinase in normal and malignant tissues. Cancer Res. 37:1977;1593-1597.
5. Arnér E.S.J., Eriksson S. Mammalian deoxyribonucleoside kinases. Pharmacol Ther. 67:1995;155-186.
6. Balzarini J., Herdewijn P., De Clercq E. Differential patterns of intracellular metabolism of 2′,3′-didehydro-2′,3′-dideoxythymidine and 3′-azido-2′,3′-dideoxythymidine, two potent anti-human immunodeficiency virus compounds. J Biol Chem. 264:1989;6127-6133.
7. Berger S.J., DeVries G.W., Carter J.G., Schulz D.W., Passonneau P.N., Lowry O.H., Ferrendelli J.A. The distribution of the components of the cyclic GMP cycle in retina. J Biol Chem. 255:1980;3128-3133.
8. Bestwick R.K., Moffett G.L., Mathews C.K. Selective expansion of mitochondrial nucleoside triphosphate pools in antimetabolite-treated HeLa cells. J Biol Chem. 257:1982;9300-9304.
9. Bohman C., Eriksson S. Mammalian deoxynucleoside kinases. Biochemistry (Life Sci Adv). 9:1990;11-35.
10. Bourdais J., Biondi R., Sarfati S., Guerreiro C., Lascu I., Janin J., Veron M. Cellular phosphorylation of anti-HIV nucleosides. Role of nucleoside diphosphate kinase. J Biol Chem. 271:1996;7887-7890.
11. Brady W.A., Kokoris M.S., Fitzgibbon M., Black M.E. Cloning, characterization, and modeling of mouse and human guanylate kinases. J Biol Chem. 271:1996;16734-16740.
12. Carritt B., King J., Welch H.M. Gene order and localization of enzyme loci on the short arm of chromosome 1. Ann Hum Genet. 46:1982;329-335.
13. Chishti A.H. Function of p55 and its nonerythroid homologues. Curr Opin Hematol. 5:1998;116-121.
14. Cihlar T., Chen M.S. Identification of enzymes catalyzing two-step phosphorylation of cidofovir and the effect of cytomegalovirus infection on their activities in host cells. Mol Pharmacol. 50:1996;1502-1510.
15. Cook P.J.L., Hamerton J.L. Report of the committee on the genetic constitution of chromosome 1. Cytogenet Cell Genet. 25:1979;9-20.
16. Cooney D.A., Dalal M., Mitsuya H., McMahon J.B., Nadkarni M., Balzarini J., Broder S., Johns D.G. Initial studies on the cellular pharmacology of 2′,3-dideoxycytidine, an inhibitor of HTLV-III infectivity. Biochem Pharmacol. 35:1986;2065-2068.
17. el Kouni M.H., el Kouni M.M., Naguib F.N. Differences in activities and substrate specificity of human and murine pyrimidine nucleoside phosphorylases. implications for chemotherapy with 5-fluoropyrimidines Cancer Res. 53:1993;3687-3693.
18. Fitzgibbon J., Katsanis N., Wells D., Delhanty J., Vallins W., Hunt D.M. Human guanylate kinase (GUK1). cDNA sequence, expression and chromosomal localisation FEBS Lett. 385:1996;185-188.
19. Fukami-Kobayashi K., Nosaka M., Nakazawa A., Gö M. Ancient divergence of long and short isoforms of adenylate kinase. molecular evolution of the nucleoside monophosphate kinase family FEBS Lett. 385:1996;214-220.
20. Furman P.A., Fyfe J.A., St Clair M.H., Weinhold K., Rideout J.L., Freeman G.A., Lehrman S.N., Bolognesi D.P., Broder S., Mitsuya H., Barry D.W. Phosphorylation of 3′-azido-3′-deoxythymidine and selective interaction of the 5′-triphosphate with human immunodeficiency virus reverse transcriptase. Proc Natl Acad Sci USA. 83:1986;8333-8337.
21. Gaidarov I.O., Suslov O.N., Abdulaev N.G. Enzymes of the cyclic GMP metabolism in bovine retina. I. Cloning and expression of the gene for guanylate kinase. FEBS Lett. 335:1993;81-84.
22. Gordon H.L., Bardos T.J., Chmielewicz Z.F., Ambrus J.L. Comparative study of the thymidine kinase and thymidylate kinase activities and of the feedback inhibition of thymidine kinase in normal and neoplastic human tissue. Cancer Res. 28:1968;2068-2077.
23. Hall S.W., Kuhn H. Purification and properties of guanylate kinase from bovine retinas and rod outer segments. Eur J Biochem. 161:1986;551-556.
24. Hapke D.M., Stegmann A.P., Mitchell B.S. Retroviral transfer of deoxycytidine kinase into tumor cell lines enhances nucleoside toxicity. Cancer Res. 56:1996;2343-2347.
25. Heinemann V., Hertel L.W., Grindey G.B., Plunkett W. Comparison of the cellular pharmacokinetics and toxicity of 2′,2′-difluorodeoxycytidine and 1-beta-D-arabinofuranosylcytosine. Cancer Res. 48:1988;4024-4031.
26. Heinemann V., Xu Y.Z., Chubb S., Sen A., Hertel L.W., Grindey G.B., Plunkett W. Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2′,2′-difluorodeoxycytidine. Mol Pharmacol. 38:1990;567-572.
27. Huang S.H., Tang A., Drisco B., Zhang S.Q., Seeger R., Li C., Jong A. Human dTMP kinase. gene expression and enzymatic activity coinciding with cell cycle progression and cell growth DNA Cell Biol. 13:1994;461-471.
28. Jamil T., Fisher R.A., Harris H. Studies on the properties and tissue distribution of the isozymes of guanylate kinase in man. Hum Hered. 25:1975;402-413.
29. Johansson M., Karlsson A. Differences in kinetic properties of pure recombinant human and mouse deoxycytidine kinase. Biochem Pharmacol. 50:1995;163-168.
30. Johansson M., Van Rompay A.R., Degrève B., Balzarini J., Karlsson A. Cloning and characterization of the deoxyribonucleoside kinase of Drosophila melanogaster. J Biol Chem. 274:1999;23814-23819.
31. Johansson N.G., Eriksson S. Structure-activity relationships for phosphorylation of nucleoside analogs to monophosphates by nucleoside kinases. Acta Biochim Pol. 43:1996;143-160.
32. Karlsson A., Reichard P., Eckstein F. The metabolism of 3′-azido-2′,3′-dideoxyguanosine in CEM cells. Biochem Biophys Res Commun. 166:1990;273-279.
33. Kim Y.K., Wells S., Lau Y.F., Lee A.S. Sequences contained within the promoter of the human thymidine kinase gene can direct cell-cycle regulation of heterologous fusion genes. Proc Natl Acad Sci USA. 85:1988;5894-5898.
34. Lavie A., Schlichting I., Vetter I.R., Konrad M., Reinstein J., Goody R.S. The bottleneck in AZT activation. Nat Med. 3:1997;922-924.
35. Lavie A., Ostermann N., Brundiers R., Goody R.S., Reinstein J., Konrad M., Schlichting I. Structural basis for efficient phosphorylation of 3′-azidothymidine monophosphate by Escherichia coli thymidylate kinase. Proc Natl Acad Sci USA. 95:1998;14045-14050.
36. Lee L.S., Cheng Y. Human thymidylate kinase. Purification, characterization, and kinetic behavior of the thymidylate kinase derived from chronic myelocytic leukemia. J Biol Chem. 252:1977;5686-5691.
37. Lee Y., Kim J.W., Lee I.A., Kang H.B., Choe Y.-K., Lee H.G., Lim J.-S., Kim H.J., Park C., Choe I.S. Cloning and characterization of cDNA for human adenylate kinase 2A. Biochem Mol Biol Int. 39:1996;833-842.
38. Liang P., Averboukh L., Zhu W., Haley T., Pardee A.B. Molecular characterization of the murine thymidylate kinase gene. Cell Growth Differ. 6:1995;1333-1338.
39. Maehara Y., Moriguchi S., Emi Y., Watanabe A., Kohnoe S., Tsujitani S., Sugimachi K. Comparison of pyrimidine nucleotide synthetic enzymes involved in 5-fluorouracil metabolism between human adenocarcinomas and squamous cell carcinomas. Cancer. 66:1990;156-161.
40. Maness P., Orengo A. A pyrimidine nucleoside monophosphate kinase from rat liver. Biochemistry. 14:1975;1484-1489.
41. Matsuura S., Igarashi M., Tanizawa Y., Yamada M., Kishi F., Kajii T., Fujii H., Miwa S., Sakurai M., Nakazawa A. Human adenylate kinase deficiency associated with hemolytic anemia. A single base substitution affecting solubility and catalytic activity of the cytosolic adenylate kinase. J Biol Chem. 264:1989;10148-10155.
42. Munch-Petersen B., Cloos L., Tyrsted G., Eriksson S. Diverging substrate specificity of pure human thymidine kinases 1 and 2 against antiviral dideoxynucleosides. J Biol Chem. 266:1991;9032-9038.
43. Naesens L., Snoeck R., Andrei G., Balzarini J., Neyts J., De Clercq E. HPMPC (cidofovir), PMEA (adefovir) and related acyclic nucleoside phosphonate analogues. a review of their pharmacology and clinical potential in the treatment of viral infections Antiviral Chem Chemother. 8:1996;1-23.
44. Nakamura H., Sugino Y. Metabolism of deoxyribonucleotides. II. Enzymatic phosphorylation of deoxycytidylic acid in normal rat liver and rat ascites hepatoma cells. Cancer Res. 26:1966;1425-1429.
45. Noma T., Song S., Yoon Y.-Y., Tanaks S., Nakazawa A. cDNA cloning and tissue-specific expression of the gene encoding human adenylate kinase isozyme 2. Biochim Biophys Acta. 1395:1998;34-39.
46. Okajima T., Tanizawa K., Fukui T. Site-directed mutagenesis of AMP-binding residues in adenylate kinase. Alteration of substrate specificity. FEBS Lett. 334:1993;86-88.
47. Owens J.K., Shewach D.S., Ullman B., Mitchell B.S. Resistance to 1-beta-D-arabinofuranosylcytosine in human T-lymphoblasts mediated by mutations within the deoxycytidine kinase gene. Cancer Res. 52:1992;2389-2393.
48. m 5′-nucleotidase effects of overexpression of the cloned cDNA in cultured human cells. Eur J Biochem. 261:1999;689-697.
49. Reichard P. Interactions between deoxyribonucleotide and DNA synthesis. Annu Rev Biochem. 57:1988;349-374.
50. Ruiz van Haperen V.W., Veerman G., Vermorken J.B., Peters G.J. 2′,2′-Difluoro-deoxycytidine (gemcitabine) incorporation into RNA and DNA of tumour cell lines. Biochem Pharmacol. 46:1993;762-766.
51. Ruiz van Haperen V.W., Veerman G., Eriksson S., Boven E., Stegmann A.P., Hermsen M., Vermorken J.B., Pinedo H.M., Peters G.J. Development and molecular characterization of a 2′,2′-difluorodeoxycytidine-resistant variant of the human ovarian carcinoma cell line A2780. Cancer Res. 54:1994;4138-4143.
52. Schinazi R.F., Goudgaon N.M., Fulcrand G., el Kattan Y., Lesnikowski Z., Ullas G., Moravek J., Liotta D.C. Cellular pharmacology and biological activity of 5-carboranyl-2′-deoxyuridine. Int J Radiat Oncol Biol Phys. 28:1994;1113-1120.
53. Schneider B., Xu Y.W., Sellam O., Sarfati R., Janin J., Veron M., Deville-Bonne D. Pre-steady state of reaction of nucleoside diphosphate kinase with anti-HIV nucleotides. J Biol Chem. 273:1998;11491-11497.
54. Sjoberg A.H., Wang L., Eriksson S. Substrate specificity of human recombinant mitochondrial deoxyguanosine kinase with cytostatic and antiviral purine and pyrimidine analogs. Mol Pharmacol. 53:1998;270-273.
55. Su J.Y., Sclafani R.A. Molecular cloning and expression of the human deoxythymidylate kinase gene in yeast. Nucleic Acids Res. 19:1991;823-827.
56. Tallman M.S., Hakimian D. Purine nucleoside analogs. emerging roles in indolent lymphoproliferative disorders Blood. 86:1995;2463-2474.
57. Tanabe T., Yamada M., Noma T., Kajii T., Nakazawa A. Tissue-specific and developmentally regulated expression of the genes encoding adenylate kinase isozymes. J Biochem. 113:1993;200-207.
58. Tomasselli A.G., Noda L.H. Mitochondrial GTP-AMP phosphotransferase. 2. Kinetic and equilibrium dialysis studies. Eur J Biochem. 93:1979;263-270.
59. Ullman B., Coons T., Rockwell S., McCartan K. Genetic analysis of 2′,3′-dideoxycytidine incorporation into cultured human T lymphoblasts. J Biol Chem. 263:1988;12391-12396.
60. Van Rompay A.R., Johansson M., Karlsson A. Identification of a novel human adenylate kinase. cDNA cloning, expression analysis, chromosome localization and characterization of the recombinant protein Eur J Biochem. 261:1999;509-516. a.
61. Van Rompay A.R., Johansson M., Karlsson A. Phosphorylation of deoxycytidine analog monophosphates by UMP-CMP kinase; molecular characterisation of the human enzyme. Mol Pharmacol. 56:1999;562-569. b.
62. Van Rompay K.K.A., Cherrington J.M., Marthas M.L., Lamy P.D., Dailey P.J., Canfield D.R., Tarara R.P., Bischofberger N., Pedersen N.C. 9-[2-(Phosphonomethoxy)propyl]adenine (PMPA) therapy prolongs survival of infant macaques inoculated with simian immunodeficiency virus with reduced susceptibility to PMPA. Antimicrob Agents Chemother. 43:1999;802-812.
63. Vilpo J.A., Vilpo L.M. Nucleoside monophosphate kinase may be the key enzyme preventing salvage of DNA 5-methylcytosine. Mutat Res. 286:1993;217-220.
64. Wang J., Eriksson S. Phosphorylation of the anti-hepatitis B nucleoside analog 1-(2′-deoxy-2′-fluoro-1-beta-D-arabinofuranosyl)-5-iodouracil (FIAU) by human cytosolic and mitochondrial thymidine kinase and implications for cytotoxicity. Antimicrob Agents Chemother. 40:1996;1555-1557.
65. Wang L., Karlsson A., Arner E.S., Eriksson S.J. Substrate specificity of mitochondrial 2′-deoxyguanosine kinase. Efficient phosphorylation of 2-chlorodeoxyadenosine. Biol Chem. 268:1993;22847-22852.
66. Wilson D.E., Povey S., Harris H. Adenylate kinases in man. evidence for a third locus Ann Hum Genet. 39:1976;305-313.
67. Xu G., O'Connell P., Stevens J., White R. Characterization of human adenylate kinase 3 (AK3) cDNA and mapping of the AK3 pseudogene to an intron of the NF1 gene. Genomics. 13:1992;537-542.
68. Xu Y., Sellam O., Morera S., Sarfati S., Biondi R., Veron M., Janin J. X-ray analysis of azido-thymidine diphosphate binding to nucleoside diphosphate kinase. Proc Natl Acad Sci USA. 94:1997;7162-7165.
69. Yamada M., Shahjahan M., Tanabe T., Kishi F., Nakazawa A. Cloning and characterization of cDNA for mitochondrial GTP:AMP phosphotransferase of bovine liver. J Biol Chem. 264:1989;19192-19199.
70. Yan H., Tsai M.D. Nucleoside monophosphate kinases. structure, mechanism, and substrate specificity Adv Enzymol Relat Areas Mol Biol. 73:1999;103-134.
71. Yoneda T., Sato M., Maeda M., Takagi H. Identification of a novel adenylate kinase system in brain. cloning of the fourth adenylate kinase Mol Brain Res. 62:1998;187-195.
72. Zhu C., Johansson M., Permert J., Karlsson A. Phosphorylation of anticancer nucleoside analogs by human mitochondrial deoxyguanosine kinase. Biochem Pharmacol. 56:1998;1035-1040. a.
73. Zhu C., Johansson M., Permert J., Karlsson A. Enhanced cytotoxicity of nucleoside analogs by overexpression of mitochondrial deoxyguanosine kinase in cancer cell lines. J Biol Chem. 273:1998;14707-14711. b.
74. Zschocke P.D., Schiltz E., Schulz G.E. Purification and sequence determination of guanylate kinase from pig brain. Eur J Biochem. 213:1993;263-269.